“…The drug is primarily used in the treatment of hodgkin's disease, bronchial carcinoma, and malignant myeloma (Spivack, 1974). The compound is of special interest because it is negative in the Salmonella/microsome test (McCann et al, 1975) but positive in various mammalian systems for mutagenicity (Ehling and Neuhauser, 1977;Roberts et al, 1979;Wild, 1978), and produces sperm abnormalities in mice . Furthermore, it has been shown that procarbazine disrupts spermatogenesis by arresting germcell populations, thereby causing the cellular associations within the seminiferous epithelium to become asynchronous (Russell et al, 1983).…”